First Time Loading...

Editas Medicine Inc
NASDAQ:EDIT

Watchlist Manager
Editas Medicine Inc Logo
Editas Medicine Inc
NASDAQ:EDIT
Watchlist
Price: 5.47 USD 4.99% Market Closed
Updated: May 2, 2024

Editas Medicine Inc
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Editas Medicine Inc
Total Other Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
Editas Medicine Inc
NASDAQ:EDIT
Total Other Income
-$1.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Other Income
-$4.7B
CAGR 3-Years
6%
CAGR 5-Years
-204%
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Total Other Income
$252m
CAGR 3-Years
22%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Total Other Income
$2.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Other Income
-$15.3m
CAGR 3-Years
N/A
CAGR 5-Years
-61%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Other Income
-$20m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-58%

See Also

What is Editas Medicine Inc's Total Other Income?
Total Other Income
-1.6m USD

Based on the financial report for Dec 31, 2023, Editas Medicine Inc's Total Other Income amounts to -1.6m USD.